Document Detail

Mortality of bullous pemphigoid in the first year after diagnosis: a retrospective study in a Spanish medical centre.
MedLine Citation:
PMID:  23279207     Owner:  NLM     Status:  Publisher    
Background  Prognosis of patients with bullous pemphigoid (BP) is controversial, with a 1-year mortality rate ranging from 6% to 48%. Objective  To determine the mortality rate of a large cohort of patients with BP and to identify prognostic factors associated with early mortality. Methods  Patients diagnosed with BP between January 1, 1990 and December 31, 2010 in a referral unit for blistering skin diseases at a university hospital in Spain were studied retrospectively. Outcome measures were mortality rate during the first year after diagnosis, standardized mortality rate and poor prognostic factors. Results  A total of 101 patients were included in the study. The mean patient age at diagnosis was 77.8 years, and 52 (51.5%) were men. Overall mortality during the first year was 12.9%. We found a standardized mortality ratio of 2.33 [CI(95 ) =( ) (1.25-4.03)]. Advanced age (patient group >80 years old) was the only risk factor for lethal outcome found, with a multivariate risk estimate of 1.09 [CI(95 ) =( ) (1.02-1.16)]. No significant association with mortality was detected for comorbidities, hospitalization history or treatment received for BP. Conclusions  We found an increased mortality of our BP patients compared with the general population. The mortality rate of BP patients was 2.3 times the expected rate. Observed mortality rate was lower than described in previous European studies. Advanced age impacts the prognosis of patients with BP. Specific treatment for BP appeared not to influence survival.
A Gual; J M Mascaró; S Rojas-Farreras; A Guilabert; M Julià; P Iranzo
Related Documents :
23306827 - Outcomes following endovascular or open repair for ruptured abdominal aortic aneurysm i...
10543267 - A placebo controlled study of albendazole in the treatment of pulmonary echinococcosis.
22748987 - Three-dimensional assessment of mandibular and glenoid fossa changes after bone-anchore...
8580617 - Follow-up of antibodies to growth hormone in 210 growth hormone-deficient children trea...
23895217 - Selective deprotection method of n-phenylcarbamoyl group.
24400647 - The incidence of phrenic nerve injury during pulmonary vein isolation using the second-...
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2012-12-22
Journal Detail:
Title:  Journal of the European Academy of Dermatology and Venereology : JEADV     Volume:  -     ISSN:  1468-3083     ISO Abbreviation:  J Eur Acad Dermatol Venereol     Publication Date:  2012 Dec 
Date Detail:
Created Date:  2013-1-2     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9216037     Medline TA:  J Eur Acad Dermatol Venereol     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Copyright Information:
© 2012 The Authors. Journal of the European Academy of Dermatology and Venereology © 2012 European Academy of Dermatology and Venereology.
Department of Dermatology, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Hospital Clínic. Universitat de Barcelona, Barcelona, Spain Health Economics and Outcomes Research, IMS Health, Barcelona, Spain.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Prevalence of oral lesions of autoimmune etiology in patients with primary Sjogren's syndrome.
Next Document:  Appendix Carcinoids in Childhood: Long-Term Experience at a Single Institution in Western Canada and...